Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands

We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% preva...

Descripción completa

Detalles Bibliográficos
Autores principales: Petersen, Maria Skaalum, Strøm, Marin, Christiansen, Debes Hammershaimb, Fjallsbak, Jógvan Páll, Eliasen, Eina Hansen, Johansen, Malan, Veyhe, Anna Sofía, Kristiansen, Marnar Fríðheim, Gaini, Shahin, Møller, Lars Fodgaard, Steig, Bjarni, Weihe, Pál
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2020
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588539/
https://www.ncbi.nlm.nih.gov/pubmed/32726200
http://dx.doi.org/10.3201/eid2611.202736
_version_ 1783600392400011264
author Petersen, Maria Skaalum
Strøm, Marin
Christiansen, Debes Hammershaimb
Fjallsbak, Jógvan Páll
Eliasen, Eina Hansen
Johansen, Malan
Veyhe, Anna Sofía
Kristiansen, Marnar Fríðheim
Gaini, Shahin
Møller, Lars Fodgaard
Steig, Bjarni
Weihe, Pál
author_facet Petersen, Maria Skaalum
Strøm, Marin
Christiansen, Debes Hammershaimb
Fjallsbak, Jógvan Páll
Eliasen, Eina Hansen
Johansen, Malan
Veyhe, Anna Sofía
Kristiansen, Marnar Fríðheim
Gaini, Shahin
Møller, Lars Fodgaard
Steig, Bjarni
Weihe, Pál
author_sort Petersen, Maria Skaalum
collection PubMed
description We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response.
format Online
Article
Text
id pubmed-7588539
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-75885392020-11-01 Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands Petersen, Maria Skaalum Strøm, Marin Christiansen, Debes Hammershaimb Fjallsbak, Jógvan Páll Eliasen, Eina Hansen Johansen, Malan Veyhe, Anna Sofía Kristiansen, Marnar Fríðheim Gaini, Shahin Møller, Lars Fodgaard Steig, Bjarni Weihe, Pál Emerg Infect Dis Research Letter We conducted a nationwide study of the prevalence of severe acute respiratory syndrome coronavirus 2 infection in the Faroe Islands. Of 1,075 randomly selected participants, 6 (0.6%) tested seropositive for antibodies to the virus. Adjustment for test sensitivity and specificity yielded a 0.7% prevalence. Our findings will help us evaluate our public health response. Centers for Disease Control and Prevention 2020-11 /pmc/articles/PMC7588539/ /pubmed/32726200 http://dx.doi.org/10.3201/eid2611.202736 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Research Letter
Petersen, Maria Skaalum
Strøm, Marin
Christiansen, Debes Hammershaimb
Fjallsbak, Jógvan Páll
Eliasen, Eina Hansen
Johansen, Malan
Veyhe, Anna Sofía
Kristiansen, Marnar Fríðheim
Gaini, Shahin
Møller, Lars Fodgaard
Steig, Bjarni
Weihe, Pál
Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
title Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
title_full Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
title_fullStr Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
title_full_unstemmed Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
title_short Seroprevalence of SARS-CoV-2–Specific Antibodies, Faroe Islands
title_sort seroprevalence of sars-cov-2–specific antibodies, faroe islands
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588539/
https://www.ncbi.nlm.nih.gov/pubmed/32726200
http://dx.doi.org/10.3201/eid2611.202736
work_keys_str_mv AT petersenmariaskaalum seroprevalenceofsarscov2specificantibodiesfaroeislands
AT strømmarin seroprevalenceofsarscov2specificantibodiesfaroeislands
AT christiansendebeshammershaimb seroprevalenceofsarscov2specificantibodiesfaroeislands
AT fjallsbakjogvanpall seroprevalenceofsarscov2specificantibodiesfaroeislands
AT eliaseneinahansen seroprevalenceofsarscov2specificantibodiesfaroeislands
AT johansenmalan seroprevalenceofsarscov2specificantibodiesfaroeislands
AT veyheannasofia seroprevalenceofsarscov2specificantibodiesfaroeislands
AT kristiansenmarnarfriðheim seroprevalenceofsarscov2specificantibodiesfaroeislands
AT gainishahin seroprevalenceofsarscov2specificantibodiesfaroeislands
AT møllerlarsfodgaard seroprevalenceofsarscov2specificantibodiesfaroeislands
AT steigbjarni seroprevalenceofsarscov2specificantibodiesfaroeislands
AT weihepal seroprevalenceofsarscov2specificantibodiesfaroeislands

Ejemplares similares